Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1987-02-27
1988-12-06
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
2603975, A61K 3156, C07J 100
Patent
active
047896710
ABSTRACT:
14,17.beta.-ethano-14.beta.-estratriene and estratetraene of Formula I ##STR1## wherein R.sup.1 is a hydrogen atom, a methyl or an acyl group of a monocarboxyclic acid of 1-12 carbon atoms,
REFERENCES:
Bull et al., J. Chem. Soc., Chem. Commun, 1986, pp. 451-453.
Bischofberger et al., Tetrahedron, vol. 41, No. 2, 1985, pp. 365-374.
Bull et al., J. Chem. Soc. Perkin Trans. I 1983, pp. 2723-2727.
Groen et al., Tetrahedron Ltrs., vol. 23, No. 35, pp. 3611-3614, 1982.
Chemical Abstracts, Band 105, No. 17, Oct. 27, 1986, J. R. Bull et al., "Cycloaddition . . . " J. Chem. Soc. 1986 (VI), 451-453.
Journal of Medicinal Chemistry, Band 16, No. 3, Mar. 1973, Solo et al., "Ring D Bridged Steroid Analogs . . . ", 270-273.
Bull James R.
Laurent Henry
Schroeder Helmut
Thomson Russell I.
Wiechert Rudolf
Lipovsky Joseph A.
Schenkman Leonard
Schering Aktiengesellschaft
LandOfFree
14,17.beta.-ethano-14.beta.-estratrienes and estratetraenes, pro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 14,17.beta.-ethano-14.beta.-estratrienes and estratetraenes, pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 14,17.beta.-ethano-14.beta.-estratrienes and estratetraenes, pro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1494209